561 results on '"Cordeiro-da-Silva, Anabela"'
Search Results
2. The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents
3. Design, synthesis and biological evaluation of antiparasitic dinitroaniline-ether phospholipid hybrids
4. Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents
5. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
6. Sand flies: Basic information on the vectors of leishmaniasis and their interactions with Leishmania parasites
7. Ending Malaria: Where Are We?
8. Exploring hydrophilic 2,2-di(indol-3-yl)ethanamine derivatives against Leishmania infantum.
9. Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign
10. High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents
11. The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents
12. Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics
13. Metabolic Crosstalk Between Host and Parasitic Pathogens
14. Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform
15. Synthesis and Evaluation of Marine-Inspired Compounds Result in Hybrids with Antitrypanosomal and Antileishmanial Activities
16. Aryl thiosemicarbazones for the treatment of trypanosomatidic infections
17. Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle
18. AMPK in Pathogens
19. Murine infection with bioluminescent Leishmania infantum axenic amastigotes applied to drug discovery
20. Intramacrophage lipid accumulation compromises T cell responses and is associated with impaired drug therapy against visceral leishmaniasis.
21. Quantification of Leishmania Parasites in Murine Models of Visceral Infection
22. In Vitro Infections of Macrophage-Like Cell Lines with Leishmania infantum for Drug Screening
23. The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques
24. Characterization and Proteomic Analysis of Plasma EVs Recovered from Healthy and Diseased Dogs with Canine Leishmaniosis
25. Advances in Leishmania Research: From Basic Parasite Biology to Disease Control
26. Development and validation of HPLC method with fluorometric detection for quantification of bisnaphthalimidopropyldiaminooctane in animal tissues following administration in polymeric nanoparticles
27. Silent Information Regulator 2 from Trypanosoma cruzi Is a Potential Target to Infection Control
28. Biomarkers in Leishmaniasis: From Basic Research to Clinical Application
29. Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis
30. Evaluating the Role of Host AMPK in Leishmania Burden
31. Drug Discovery for Human African Trypanosomiasis: Identification of Novel Scaffolds by the Newly Developed HTS SYBR Green Assay for Trypanosoma brucei
32. Synthesis and Biological Evaluation of Amphotericin B Formulations Based on Organic Salts and Ionic Liquids against Leishmania infantum
33. Serological and Molecular Survey of Leishmania infantum in a Population of Iberian Lynxes (Lynx pardinus)
34. Leishmania Vesicle-Depleted Exoproteome: What, Why, and How?
35. Investigating the mechanism of action of the antiparasitic agent H80 through imaging techniques
36. Use of Antigen Combinations to Address Complex Leishmania-Seropositivity Patterns in Dogs Living in Canine Leishmaniosis Endemic Regions of Portugal
37. Pyrimido[5,4-d]pyrimidine-Based Compounds as a Novel Class of Antitrypanosomal and Antileishmanial Agents
38. Crucial CD8+ T-lymphocyte cytotoxic role in amphotericin B nanospheres efficacy against experimental visceral leishmaniasis
39. Current Treatments to Control African Trypanosomiasis and One Health Perspective
40. Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1
41. Immunization with CSP and a RIG-I Agonist is Effective in Inducing a Functional and Protective Humoral Response Against Plasmodium
42. Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1
43. Exoproteome dynamics in Leishmania infantum
44. In vitro evaluation of bisnaphthalimidopropyl derivatives loaded into pegylated nanoparticles against Leishmania infantum protozoa
45. Discovery of guanidino-containing benzimidazoles as novel antifolates for Trypanosomiasis
46. Indole-Containing Pyrazino[2,1-b]quinazoline-3,6-diones Active against Plasmodium and Trypanosomatids
47. Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant
48. Multitarget, Selective Compound Design Yields Picomolar Inhibitors of a Kinetoplastid Pteridine Reductase 1
49. Differential roles of PI3-Kinase, MAPKs and NF-κB on the manipulation of dendritic cell T h1/T h2 cytokine/chemokine polarizing profile
50. Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.